Department of Health and Human Services
Food and Drug Administration
- [Docket No. FDA-2020-N-0026]
AGENCY:
Food and Drug Administration, Health and Human Services (HHS).
ACTION:
Notice; withdrawal.
SUMMARY:
The Food and Drug Administration (FDA) is withdrawing the notice that published in the Federal Register of September 30, 2021, that announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Register notice was published in error and is being withdrawn.
FOR FURTHER INFORMATION CONTACT:
Stephen Ripley, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-402-7911.